Clinical Insights on Emerging Misuse of Performance and Image Enhancing Drugs
-
Register
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
Clinical Insights on Emerging Misuse of Performance and Image Enhancing Drugs
Recorded: Thursday, April 23, 2026 to Sunday, April 26, 2026
On-Demand Session
Overview
This 75-minute on-demand session from the ASAM 57th Annual Conference addresses performance and image enhancing drug misuse, exploring health risks, psychosocial factors, and evidence-based screening and management strategies.
This interactive workshop explores the expanding use of Performance and Image Enhancing Drugs (PIEDs)-from peptides and testosterone to GLP-1 agonists-across athletic, wellness, and anti-aging settings. Participants will review pharmacologic mechanisms, psychosocial drivers, and addiction parallels, applying DEI principles to understand gender, cultural, and socioeconomic influences on access and stigma. Through case-based discussion and polling, clinicians will gain practical strategies for screening, counseling, and managing patients engaged in PIED use within diverse clinical contexts.
The target audience for this Intermediate level session includes physicians, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, and students.
This session addresses the following ACGME Competencies: Patient Care and Procedural Skills, Medical Knowledge.
This session addresses the following IPEC Competencies: Values and Ethics, Communication.
Learning Objectives
Upon completion, learners will be able to:
- Describe the major classes, mechanisms, and health risks of commonly used Performance and Image Enhancing Drugs (PIEDs).
- Identify psychosocial and behavioral factors such as body image, gender norms, and cultural influences that contribute to PIED misuse and related health disparities.
- Apply evidence-based and culturally responsive strategies for screening, counseling, and managing patients who use PIEDs in both athletic and non-athletic settings.
Registration Rates
| Rate Description | Rate |
| ASAM Member | $29 |
| Non-Member | $39 |
| Associate Member | $19 |
| Resident Member* | $19 |
| Student Member* | $19 |
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 05/25/2026 - 04/25/2029
User Access Closed: 05/25/2029
Course Instructions
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. You will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Timothy Wiegard
MD
Dr. Wiegand holds board certification in internal medicine, medical toxicology and clinical pharmacology. He completed his Postgraduate Fellowships in Medical Toxicology and Clinical Pharmacology at the University of California, San Francisco in 2006. His current position is as the Director of Toxicology at the University of Rochester Medical Center in Rochester, New York where he holds an appointment in Emergency Medicine as Associate Clinical Professor of Emergency Medicine at Strong Memorial Hospital and Highland Hospital. In addition to his positions at the University of Rochester Dr. Wiegand Directs the Toxicology Consult Service at Strong Memorial and Highland Hospitals, serves as Medical Director of Huther-Doyle Chemical Dependency treatment program in Rochester, NY, and treats acute alcohol and opioid withdrawal at the Syracuse Behavioral Health (SBH) Rochester detoxification facility. He is also faculty for the SUNY Upstate Medical Toxicology Fellowship training program and serves as on-call toxicologist for the SUNY Upstate Poison Center. Dr. Wiegand directs a clinical rotation in medical toxicology for the Strong Memorial Hospital Emergency Medicine residency program and is involved in toxicology, pharmacology and addiction medicine education for fellows, residents, and students in pharmacy and medicine. His interests include the treatment of acute intoxication and treatment of alcohol, opioid and other drug withdrawal syndromes and in the treatment and prevention of addiction and dependence. He has been treating opioid dependence since 2005 as an SAMHSA-waived OBOT provider. Dr. Wiegand has published in the areas of acute intoxication, withdrawal and treatment and prevention of drug overdose and in medical education in toxicology and emergency medicine and in the development, billing and reimbursement related to clinical toxicology practice. He is a section editor for the Encyclopedia of Toxicology, 3rd edition and has published numerous journal articles and textbook chapters on toxicology and related topics. Dr. Wiegand won the 2013 American Society of Addiction Medicine (ASAM) Annual MedSci research award for best abstract for research involving addiction medicine education during medical toxicology fellowship training. Dr. Wiegand is the Chair for the American College of Medical Toxicology (ACMT) Addiction Medicine section and he was appointed to the New York chapter of the American Society of Addiction Medicine (NYSAM) Board of Governors as Communication Committee Chair and Board Member in 2013. He has been increasingly active in ASAM and in his state chapter, NYSAM, since 2011.
Jeffrey Brent, MD, PhD
Distinguished Clinical Professor
University of Colorado School of Medicine
Jeffrey Brent, M.D., Ph.D., is a Distinguished Clinical Professor of Medicine and Emergency Medicine at the University of Colorado School of Medicine. He currently serves as co-Principle Investigator of the Toxicology Investigators Consortium, an NIH, FDA, and CDC-funded multicenter research consortium in medical toxicology. Among Dr. Brent’s accomplishments are career achievement awards from the American Academy of Clinical Toxicology, The American College of Medical Toxicology, The European Association of Clinical Toxicologists and Poisons Centres, and the Society of Toxicology. He has over 200 peer-reviewed publications and is the Senior Editor for the textbook Critical Care Toxicology – The Diagnosis and Management of the Critically Poisoned Patient, now in its second edition.
Stephanie T. Weiss
MD, PhD
Stephanie T. Weiss, MD PhD is the staff Research Physician serving the Translational Addiction Medicine Branch (TAMB) of the NIDA Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree from Cleveland Clinic Lerner College of Medicine. She is board certified in emergency medicine and medical toxicology, a subspecialty that cares for patients with poisonings, environmental exposures, and overdoses. She subsequently completed a second fellowship in addiction medicine research and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss assumes responsibility for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.
No relevant financial disclosures.
Jason Kirby
DO, MBA, FASAM
Dr. Jason Kirby, DO, MBA, FASAM is a board-certified Addiction Medicine specialist and is currently Chief Medical Officer of Landmark Recovery, a national drug and alcohol residential treatment organization based in Franklin, TN. He is certified by the American Board of Preventive Medicine. He has treated thousands of patients in his career struggling from a variety of substance use disorders and practices full time Addiction Medicine for Landmark Recovery. Dr. Kirby is the clinical leader for the organization and is responsible for the development of Landmark's policies and procedures governing evidence based and harm reduction practices as well as liaison for all regulatory matters.
He also serves in leadership in the American Society of Addiction Medicine as member of the Finance and Level of Care Committees, faculty for ASAM's Opioid Treatment Course, and was granted Fellow status in May 2020. Recently, he was nominated as President - Elect of the Tennessee Chapter of ASAM. Dr. Kirby has spoken at a variety of conferences and given lectures and grand rounds focusing on diagnosis, prevention, and treatment of substance use disorders and other process addictions in special populations.
Dr. Kirby has a deep personal passion for helping patients who use substances to regain functionality in their lives and enter programs of recovery.
No Relevant Financial Disclosures
Stephen Taylor
MD, MPH, DFAPA, DFASAM
Pathway Healthcare
Stephen M. Taylor, MD, MPH, DFAPA, DFASAM is the Chief Medical Officer of Pathway Healthcare, a company that operates 13 outpatient mental health and addiction treatment offices across Alabama, Mississippi, Tennessee, and Texas. Dr. Taylor is board-certified in psychiatry, child and adolescent psychiatry, addiction psychiatry, and addiction medicine. Dr. Taylor is in his 15th season as the Medical Director of the Player Assistance/Anti-Drug Program of the National Basketball Association (NBA) and the National Basketball Players Association (NBPA).
Dr. Taylor is a Distinguished Fellow of the American Psychiatric Association, and a Distinguished Fellow of the American Society of Addiction Medicine (DFASAM). He is Vice Chair of ASAM’s Legislative Advocacy Committee and serves on ASAM’s Public Policy Committee. He is co-chair of ASAM’s Writing Subcommittee on Advancing Racial Justice, which drafted ASAM’s Public Policy Statement on Advancing Racial Justice in Addiction Medicine. He also chairs ASAM’s Delegation to the AMA House of Delegates and is a member of the ASAM Board of Directors.
Dr. Taylor is a certified Medical Review Officer (MRO) and serves on the Board of Directors of the Medical Review Officer Certification Council (MROCC). He also serves on the Drug Testing Advisory Board (DTAB) of the Center for Substance Abuse Prevention of the Substance Abuse and Mental Health Services Administration (SAMHSA), and he serves on the Board of Directors of the Addiction Prevention Coalition, a non-profit community organization in Birmingham, AL.
An honors graduate of Harvard College, with a Master of Public Health degree from the Harvard School of Public Health and a medical degree from Howard University College of Medicine, Dr. Taylor completed “Triple Board” residency in pediatrics, psychiatry, and child and adolescent psychiatry at the Albert Einstein College of Medicine/Bronx Municipal Hospital Center, then completed a fellowship in addiction psychiatry at NYU School of Medicine/Bellevue Hospital Center.
No Financial Disclosures.
Accreditation & Credit Designation Statements
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The American Society of Addiction Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This activity awards 1.25 Nursing contact hours.
PAs
ASAM has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1.25 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 05/25/2029. PAs should only claim credit commensurate with the extent of their participation.
Social Workers
As a Jointly Accredited Organization, ASAM is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: # OS-20-330-0227.
Other Professions - Continuing Education Credits (CEUs)
Upon completion of the activity and online evaluation, all other participants may request a certificate of participation. Participants may submit this certificate of participation to their professional organization/institute as documentation for completing this accredited continuing activity.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABIM, ABP and ABS. By completing the online credit claim and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
American Board of Anesthesiology (ABA)
This activity offers up to 1.25 CME credits, of which 1.25 credits contribute the patient safety CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Maintenance of Certification in Anesthesiology® and MOCA® are registered certification marks of the American Board of Anesthesiology®
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Preventive Medicine (ABPM)
This activity has been designed to satisfy the Lifelong Professional Development requirements of The American Board of Preventive Medicine’s Continuing Certification (CCP) requirements. These credits are not reported directly to ABPM. Please save your certificate for your records.
American Board of Psychiatry and Neurology (ABPN)
This activity has been designed to satisfy the CME requirements of the American Board of Psychiatry and Neurology’s Continuing Certification (CC) requirements. These credits are not reported directly to ABPN. Please save your certificate for your records.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Royal College of Physicians and Surgeons of Canada (RCPSC)
The Royal College of Physicians and Surgeons of Canada will recognize activities registered for CME for MOC as meeting the requirements for Royal College MOC Program Section 3 (Self-Assessment Programs) credits. Visit CME that Counts for Royal College MOC for more information.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education. Click here to view the full disclosure listing.
Key:
Complete
Next
Failed
Available
Locked